Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Colistin plus rifampicin versus colistin alone for severe multidrug-resistant Acinetobacter baumannii infections
2008-005078-10Phase 3Active
- Sponsor
- Monaldi Hospital
- Start
- Dec 2008
- Modality
- Peptides, Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised, open-label trial in Acinetobacter baumannii infection comparing Colistin + rifampicin with Colistin alone (2 arms). Primary endpoint: Disease-specific mortality. Started Dec 2008; status: active.
02
Drugs
colistinrifampicin
03
Conditions
Acinetobacter baumannii infection
Beyond the preview
Go deeper on 2008-005078-10.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2008-005078-10.